首页> 外文期刊>Molecular Genetics and Metabolism Reports >Pyridoxine responsive epilepsy caused by a novel homozygous PNPO mutation
【24h】

Pyridoxine responsive epilepsy caused by a novel homozygous PNPO mutation

机译:新型纯合PNPO突变引起的吡y醇反应性癫痫

获取原文
           

摘要

We report a patient with anti-epileptic treatment refractory neonatal seizures responsive to pyridoxine. Biochemical analysis revealed normal markers for antiquitin deficiency and also mutation analysis of the ALDH7A1 ( Antiquitin ) gene was negative. Mutation analysis of the PNPO gene revealed a novel, homozygous, presumed pathogenic mutation (c.481C > T; p.(Arg161Cys)). Measurements of B6 vitamers in a CSF sample after pyridoxine administration revealed elevated pyridoxamine as the only metabolic marker for PNPO deficiency. With pyridoxine monotherapy the patient is seizure free and neurodevelopmental outcome at the age of 14 months is normal.
机译:我们报告了抗癫痫治疗难治性新生儿癫痫发作对吡ido醇有反应的患者。生化分析显示抗排蛋白缺乏症的正常标志物,ALDH7A1(抗排蛋白)基因的突变分析为阴性。 PNPO基因的突变分析揭示了一种新的,纯合的,推测的致病突变(c.481C> T; p。(Arg161Cys))。吡ido醇给药后脑脊液中B 6 维生素的测量结果表明,吡pyr醇胺升高是PNPO缺乏的唯一代谢指标。吡ido醇单药治疗可使患者无癫痫发作,并且14个月大时的神经发育结果正常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号